RxDoctor Payments Data

Christine Doyle

Acute Care · Naperville, ILNPI 1811258460

Payments from drug & device makers

$848in general payments, 2019–2025

Across 25 payments — averaging $33.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$253
  • Kestra Medical Technology Services, Inc.$138
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$133
  • Amgen$87
  • Nuwellis, Inc.$56
  • Johnson & Johnson$50
  • plus $131 from 5 others

What the payments were for

  • Food & beverage$83799%
  • Education$111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$848 in reported general payments places this provider in the 75th percentile of 461 acute care providers in Illinois.

See all acute care providers in Illinois

Medicare billing

Part B allowed, 2024
$10,058
Medicare patients
117
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$35,166
JardianceEmpagliflozin12$7,745
Dofetilide14$2,583
Metoprolol Succinate79$840
Amiodarone Hcl34$765
Diltiazem 24hr ErDiltiazem Hcl17$452
ClopidogrelClopidogrel Bisulfate68$423
Torsemide20$188
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$147
Metoprolol Tartrate20$115
Losartan Potassium23$83
Atorvastatin Calcium15$83
Furosemide32$73
Carvedilol15$50
Amlodipine Besylate17$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$35,16660 claims
Boehringer IngelheimJardiance$24$7,74512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 461 acute care providers in Illinois.

Other acute care in Naperville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →